Valuation Photocure ASA

Stocks

Market Closed - Oslo Bors 12:45:00 12/09/26 am AEST			5-day change	1st Jan Change
51.90 ^NOK	-2.44%		-2.99%	-27.31%

16/08	Photocure Sees Potential in US FDA's Proposed Reclassification of Cystoscopy Systems	MT
15/08	Photocure ASA Initiates FDA Proposal To Reclassify Blue Light Cystoscopy Systems From Class III To Class II	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	2,769	2,895	1,827	1,681	1,900	1,397	-	-
Change	-	4.55%	-36.89%	-8.01%	13.04%	-26.46%	-	-
Enterprise Value (EV) ¹	2,483	2,639	1,567	1,387	1,661	1,228	1,240	1,237
Change	-	6.28%	-40.61%	-11.53%	19.77%	-26.06%	0.98%	-0.22%
P/E	-89.3x	-40.2x	6,740x	-344x	-1,190x	18.3x	66.5x	44.7x
PBR	-	-	-	-	-	3.88x	3.56x	3.35x
PEG	-	-0x	-67x	0x	17.9x	-0x	-0.9x	0.9x
Capitalization / Revenue	7.68x	7.73x	4.09x	3.42x	3.57x	2.12x	2.1x	1.94x
EV / Revenue	6.89x	7.05x	3.51x	2.82x	3.12x	1.87x	1.86x	1.72x
EV / EBITDA	136x	-107x	28.2x	28.2x	57.8x	11.6x	17x	14.3x
EV / EBIT	-426x	-53.9x	56.4x	68x	-2,229x	11.1x	29.3x	22.6x
EV / FCF	113x	-469x	35.4x	18.4x	95x	18.6x	109x	50.8x
FCF Yield	0.89%	-0.21%	2.82%	5.43%	1.05%	5.37%	0.91%	1.97%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	-1.15	-2.66	0.01	-0.18	-0.06	2.83	0.78	1.16
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	360.5	374.5	446.2	491.7	532.6	658.3	666.3	720.3
EBITDA ¹	18.3	-24.63	55.49	49.19	28.73	105.7	73	86.67
EBIT ¹	-5.826	-49	27.81	20.4	-0.745	110.3	42.33	54.67
Net income ¹	-30.9	-71.86	0.267	-4.81	-1.519	76.33	21	31.67
Net Debt ¹	-285.4	-255.6	-259.5	-293.9	-238.9	-169	-157	-159.7
Reference price ²	102.70	106.80	67.40	62.00	71.40	51.90	51.90	51.90
Nbr of stocks (in thousands)	26,960	27,106	27,106	27,106	26,607	26,917	-	-
Announcement Date	23/2/22	23/2/23	21/2/24	19/2/25	18/2/26	-	-	-

¹NOK in Million²NOK

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
PHOTOCURE ASA	18.34x	1.87x	11.62x	-	150M
ELI LILLY AND COMPANY	31.77x	11.54x	23.41x	0.62%	994B
JOHNSON & JOHNSON	29.54x	-	-	2.02%	640B
ABBVIE INC.	32.92x	7.63x	15.78x	2.67%	454B
ROCHE HOLDING AG	18.71x	4.57x	11.31x	2.91%	337B
NOVARTIS AG	19.41x	5.08x	12.59x	3.23%	261B
ASTRAZENECA PLC	20.34x	4.19x	11.96x	2.11%	246B
AMGEN INC.	23.87x	6.3x	11.23x	2.67%	204B
NOVO NORDISK A/S	12.3x	4.48x	9.37x	4.08%	190B
GILEAD SCIENCES, INC.	-43.47x	6.35x	24.81x	2.29%	178B
Average	16.37x	5.78x	14.68x	2.51%	350.49B
Weighted average by Cap.	23.19x	7.72x	17.10x	2.05%